- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Novavax Inc+ Add to Watchlist
NVAX:US5.9000 USD 0.0400 0.68%
As of 17:20:00 ET on 03/11/2014.
Company Profile for Novavax Inc (NVAX)
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Key Executives for Novavax Inc (NVAX)
|Stanley C ErckPresident/CEO||Barclay A Phillips "Buck"Senior VP/CFO|
|Timothy J HahnSenior VP:Manufacturing||Russell P Wilson "Rip"Senior VP:Business Development|
|Gregory M Glenn "Greg"Senior VP:Research & Development||John J TrizzinoSenior VP:Commercial Operations|
|Louis Fries III "Lou"VP/Chief Medical Officer||D Nigel ThomasVP:Clinical Opeartions|